Brain trauma affects millions. Learn about traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) and how they impact civilians and Veterans.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Our approach is to build enabling platforms with strategic partners and to adopt a team science approach to fast-track solutions in years, not decades.
Learn about our latest partnerships, program updates and more in our 2019 Impact Report.
Advancing Brain Health: Achievements in 2019
Advancing Diagnostics
Study Identifies Post-Traumatic Stress Disorder (PTSD) Brain Imaging Biomarker Results Show Personalized Approach May Help PTSD Sufferers Receive the Right Treatment, Sooner
Cohen Veterans Bioscience announced findings from a study which identifies a critical brain imaging biomarker that may help guide people who suffer from PTSD towards the most effective treatment.
Landmark Study Identifies Six Genetic Markers of Post-Traumatic Stress Disorder (PTSD) Risk Findings Implicate Novel Biological Pathways in PTSD, Advancing Understanding of Prevention and Treatment
Collaborative Effort Greatly Accelerated, Expanded Scope of Study to Examine More Than 30,000 Multiethnic PTSD Cases and 170,000 Controls Cohen Veterans Bioscience and the Stanley Center for Psychiatric Research at the Broad Institute at MIT and Harvard, announced findings from a study published in Nature Communications that identifies three genome wide genetic loci associated with PTSD risk. The risk of developing PTSD after experiencing trauma is heritable, but robust genetic markers had not yet been identified by previous genome-wide association studies (GWAS).
Parkinson’s Progression Markers Initiative (PPMI) Data Science Modeling Group
In an aligned mission to advance brain health, the Michael J. Fox Foundation for Parkinson’s Research selected Cohen Veteran’s Bioscience to lead data modeling efforts for the Parkinson’s Progression Markers Initiative (PPMI) study. PPMI is a multi-year, observational, multi-center study to assess progression of clinical features and imaging as well as biologic biomarkers in various populations.
Circady Wins 2019 MedTech Breakthrough Award for Innovation in Sleep Therapy Insomnia is a common symptom of PTSD that can have debilitating effects. Approximately 70-91% of PTSD patients have difficulty falling or staying asleep. Circady, an innovative insomnia treatment created from our digital health research program SleepWell, won a 2019 MedTech Breakthrough Award for Best Sleep Monitoring Solution.”
Advancing the Research Roadmap
Proceedings from the State of the Science Summit on Post-traumatic Stress Disorder The inaugural SoSS explored the state of the science in diagnosis of trauma-related brain disorders with a major focus on PTSD. Working groups surveyed the current scientific landscape, identified knowledge gaps, and considered new evidence-based scientific and clinical models to fill these gaps.
Watch Video Highlights from the State of the Science Summit on Traumatic Brain Injury The theme of the second State of the Science Summit was Paths to Treatment for Traumatic Brain Injury(s) with a focus on the taxonomy and nosology of the chronic sequelae, challenges and opportunities in clinical practice and development, and etiology and mechanism of persistent symptoms.
Advancing Advocacy
The Coalition to Heal Invisible Wounds: 2019 Progress Report In 2019, the Coalition to Heal Invisible Wounds has continued to drive an active Congressional outreach campaign aimed at making the VA a world-class partner on the most advanced research and development projects related to PTSD and TBI.
Veterans Advisory Council Names Members Cohen Veterans Bioscience is sponsoring the formation of a Veterans Advisory Council (VAC) to ensure that we deliver meaningful results for Veterans through data-driven science and advocacy.
CVB presented and participated in global events with our partners to advance brain health research and educate on our efforts throughout the year.
Wishing you a Happy & Healthy New Year from the Cohen Veterans Bioscience Team! We look forward to keeping you updated on our progress; we are proud to be on this incredibly important journey with you.
Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Manage Cookie Consent
We use cookies to optimize our website.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.